Cargando…

Long‐term efficacy and safety of adjunctive extended‐release oxcarbazepine (Oxtellar XR(®)) in adults with partial‐onset seizures

OBJECTIVE: To evaluate long‐term outcomes of adjunctive therapy with SPN‐804 (Oxtellar XR(®), Supernus Pharmaceuticals), an extended‐release tablet formulation of oxcarbazepine (OXC), in adults with refractory partial‐onset seizures. METHODS: After completing a 16‐week double‐blind, placebo‐controll...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, S. S., Johnson, J. K., Brittain, S. T., Baroldi, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042072/ https://www.ncbi.nlm.nih.gov/pubmed/26248506 http://dx.doi.org/10.1111/ane.12467

Ejemplares similares

Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial
por: French, JA, et al.
Publicado: (2014)

Predicted Efficacy of Once-Daily Extended-Release Oxcarbazepine (Oxtellar XR(®)) Monotherapy in Adults and Children with Partial-Onset Seizures: Exposure-Response Modeling and Simulation
por: Faison, Shamia, et al.
Publicado: (2020)

Levetiracetam Extended Release as Adjuvant Therapy for the Control of Partial-onset Seizures
por: Sonmezturk, Hasan H., et al.
Publicado: (2011)

Venlafaxine extended release (XR) in the treatment of panic disorder
por: Kjernisted, Kevin, et al.
Publicado: (2007)

Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures
por: Neutel, Joel M., et al.
Publicado: (2013)

Clinical utility of adjunctive retigabine in partial onset seizures in adults
por: Rejdak, Konrad, et al.
Publicado: (2012)

Efficacy of Retigabine in Adjunctive Treatment of Partial Onset Seizures in Adults
por: Splinter, Michele Y.
Publicado: (2013)

Lacosamide adjunctive therapy for partial-onset seizures: a meta-analysis
por: Sawh, Sonja C., et al.
Publicado: (2013)

Cognitive effects of adjunctive perampanel for partial‐onset seizures: A randomized trial
por: Meador, Kimford J., et al.
Publicado: (2016)

Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures
por: Ulloa, Carol M, et al.
Publicado: (2009)

Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures
por: Weisenberg, Judith LZ, et al.
Publicado: (2011)

Treating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX): Who Will Respond?
por: Nunes, Edward V., et al.
Publicado: (2015)

Critical Analysis of the Evaluation Methods of Extended Reality (XR) Experiences for Construction Safety
por: Salinas, Daniel, et al.
Publicado: (2022)

Once-daily USL255 as adjunctive treatment of partial-onset seizures: Randomized phase III study
por: Chung, Steve S, et al.
Publicado: (2014)

Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures
por: Mumoli, Laura, et al.
Publicado: (2015)

Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures
por: Lattanzi, Simona, et al.
Publicado: (2022)

Oxcarbazepine and Hyponatremia
por: Čiauškaitė, Julija, et al.
Publicado: (2022)

Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures [Corrigendum]
Publicado: (2015)

Value of Perampanel as Adjunctive Treatment for Partial-Onset Seizures in Epilepsy: Cost-Effectiveness and Budget Impact Analysis
por: Zhang, Donger, et al.
Publicado: (2021)

Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid Dependence
por: Earley, Paul H., et al.
Publicado: (2017)

A systematic review of extended reality (XR) for understanding and augmenting vision loss
por: Kasowski, Justin, et al.
Publicado: (2023)

Physiologically‐based pharmacokinetic modeling of oxcarbazepine and levetiracetam during adjunctive antiepileptic therapy in children and adolescents
por: Sinha, Jaydeep, et al.
Publicado: (2021)

Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies
por: Ben-Menachem, Elinor, et al.
Publicado: (2016)

Effect of Aptensio XR (Methylphenidate HCl Extended-Release) Capsules on Sleep in Children with Attention-Deficit/Hyperactivity Disorder
por: Owens, Judith, et al.
Publicado: (2016)

Adaptation of a standard extended-release naltrexone (XR-NTX) protocol for rural re-entering offenders with OUD
por: Staton, Michele, et al.
Publicado: (2021)

Development of an Extended-Reality (XR)-Based Intervention to Treat Adolescent Obesity
por: Malik, Neal, et al.
Publicado: (2022)

Whose mu fared better? The effect of extended-release naltrexone (XR-NTX) on treatment outcomes for opioid and alcohol users
por: Crèvecoeur-MacPhail, Desirée A
Publicado: (2015)

Desensitization to Oxcarbazepine: Long-Term Efficacy and Tolerability
por: Lee, Jiwon, et al.
Publicado: (2017)

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

Dosimetric evaluation of GAFCHROMIC® XR type T and XR type R films
por: Dini, Sharifeh A., et al.
Publicado: (2005)

Uncontrolled headache induced by oxcarbazepine
por: Piovesan, Elcio Juliato, et al.
Publicado: (2007)

Development of lacosamide for the treatment of partial-onset seizures
por: Doty, Pamela, et al.
Publicado: (2013)

The efficacy and safety of adjunctive perampanel for the treatment of refractory focal‐onset seizures in patients with epilepsy: A meta‐analysis
por: Li, Yiming, et al.
Publicado: (2022)

Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: Results from phase III extension study 307
por: Krauss, Gregory L, et al.
Publicado: (2014)

Perampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptability
por: Schulze-Bonhage, Andreas, et al.
Publicado: (2015)

Ultraviolet exposure of Gafchromic XR‐RV3 and XR‐SP2 films
por: Katsuda, Toshizo, et al.
Publicado: (2015)

The Need for Psychosocial Interventions to Facilitate the Transition to Extended-Release Naltrexone (XR-NTX) Treatment for Opioid Dependence: A Concise Review of the Literature
por: Ramsey, Susan E., et al.
Publicado: (2016)

Pharmacokinetic comparison of sitagliptin and metformin HCl extended-release tablets versus JANUMET(®) XR in healthy volunteers under fasting and fed conditions
por: Que, Linling, et al.
Publicado: (2023)

Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland
por: Väätäinen, Saku, et al.
Publicado: (2019)

Extended Reality (XR) for Condition Assessment of Civil Engineering Structures: A Literature Review
por: Catbas, Fikret Necati, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qnmvt9dooigpcmm4nvd784o28n